ArticleScientific reports2026
Improving the compatibility of INFOGEST digesta with intestinal epithelial models through post-digestion storage conditions.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The INFOGEST protocol is widely used for standardized in vitro digestion studies, but its application to cell models remains challenging due to residual enzyme activity, bile salts, and matrix effects that impair cell metabolism. This study investigated a post-digestion processing strategy to enable direct testing of INFOGEST digesta on 2D Caco-2 monolayers and intestine-on-chip systems without chemical inhibitors. Five post-digestion storage methodologies were compared: A, no storage; B, liquid nitrogen at - 80 °C; C, liquid nitrogen/freeze-drying; D, - 20 °C/freeze-drying; and E, - 20 °C. Residual enzymatic activities and effects on epithelial cell morphology and viability were evaluated, and the optimized workflow was validated in a microfluidic intestine-on-chip, including plant matrices. The condition D significantly reduced residual enzymatic activity, especially trypsin, identified as a key mediator of epithelial cell disruption. This storage method preserved Caco-2 monolayer integrity at a 25% dilution, with no cytotoxicity or cell detachment. When applied to digested Brassica oleracea and Malus domestica matrices, condition D did not compromise cell viability as evidenced by the results obtained with INFOGEST digesta in the absence of plant food matrices. In intestine-on-chip experiments, treated digesta produced stable TEER values and continuous ZO-1 localization, confirming barrier integrity. This simple freeze-then-lyophilize workflow enables a scalable and biocompatible integration of INFOGEST digestion with advanced cellular models for studying food bioaccessibility and intestinal absorption.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.